Furthermore, CD109’s potential involvement in the IL-6/GP130/STAT3 axis, a key driver of chronic inflammation and cancer stem cell survival, suggests it may help sustain an inflammatory environment that fosters metastasis and immune evasion (120, 121). Here, STAT3 is linked to cancer.